Infectious Diseases (except HIV/AIDS)
Showing page 384 of 716 pages of list content
-
SARS-CoV-2 testing strategies to contain school-associated transmission: model-based analysis of impact and cost of diagnostic testing, screening, and surveillance
This article's authors -
Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
This article's authors -
Spike-antibody responses to ChAdOx1 and BNT162b2 vaccines by demographic and clinical factors (Virus Watch study)
This article's authors -
Bayesian Model Averaging to Account for Model Uncertainty in Estimates of a Vaccine’s Effectiveness
This article's authors -
Local prevalence of transmissible SARS-CoV-2 infection: an integrative causal model for debiasing fine-scale targeted testing data
This article's authors -
SARS-CoV-2 R.1 lineage variants prevailed in Tokyo in March 2021
This article's authors -
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
This article's authors -
Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
This article's authors -
Pooling of samples for SARS-CoV-2 surveillance using a rapid antigen test
This article's authors -
Establishment of an evaluation panel for the decentralized technical evaluation of the sensitivity of 31 rapid detection tests for SARS-CoV-2 diagnostics
This article's authors